Paloma Partners’s Global Cord Blood Corporation CO Stock Holding History

Paloma Partners’s Portfolio CO Stock Details CO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-15,633	Closed	-$50K	–	2340
2020 Q1	$50K	Sell	15,633 -26,301	-63%	-$115K	﹤0.01%	1112
2019 Q4	$210K	Sell	41,934 -43,166	-51%	-$206K	﹤0.01%	1952
2019 Q3	$412K	Buy	+85,100	New	+$446K	0.01%	1304
2015 Q3	–	Sell	-37,994	Closed	-$234K	–	2132
2015 Q2	$234K	Buy	+37,994	New	+$233K	﹤0.01%	1471

Other funds holding CO

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

OMC

Oasis Management Company Grand Cayman, Cayman Islands $1.72B AUM 32.1% 1-Year Est. Return

Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return

QOP

Quinn Opportunity Partners Charlottesville, Virginia $1.92B AUM 31.26% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

PPA

Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return

Paloma Partners's CO Position: Q2 2020 in Review

Paloma Partners sold out of Global Cord Blood Corporation (CO) in Q2 2020, closing a stake of 15,633 shares — an estimated $50K sold.

Paloma Partners first reported a position in CO in Q2 2015 and held it in 4 quarters. The position peaked at $412K in Q3 2019. 32 funds tracked by Wall St. Rank hold CO as of Q2 2020.

Paloma Partners reported no remaining Global Cord Blood Corporation position as of Q2 2020 after selling out during the quarter.
Paloma Partners sold 15,633 Global Cord Blood Corporation shares in Q2 2020, an estimated $50K.
Paloma Partners first reported a position in Global Cord Blood Corporation in Q2 2015 and held it in 4 quarters.
Paloma Partners's Global Cord Blood Corporation position peaked at $412K in Q3 2019.
32 funds tracked by Wall St. Rank held Global Cord Blood Corporation as of Q2 2020.

Based on Paloma Partners's 13F filing for Q2 2020, filed 14 Aug 2020.